The innovative model will allow researchers to study neuromuscular diseases, such as Motor Neuron Disease, closer and may be suitable to screen potential treatments. Researchers from the Centre for Gene Therapy & Regenerative Medicine at King’s College London, in collaboration with colleagues from University College London, have developed the first truly scalable human iPSC-neuromuscular disease
Read More
About The Author
